المؤلفون: Wong RK, Paul N, Ding K, Whitehead M, Brundage M, Fyles A, Wilke D, Nabid A, Fortin A, Wilson D, McKenzie M, Ackerman I, Souhami L, Chabot P, Pater J

مؤلفون مشاركون: National Cancer Institute of Canada Clinical Trials Group (SC19); National Cancer Institute of Canada Clinical Trials Group, Canada. Rebecca.wong@rmp.uhn.on.ca

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2006 Jul 20; Vol. 24 (21), pp. 3458-64.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Serotonin 5-HT3 Receptor Antagonists*, Antiemetics/*therapeutic use , Dexamethasone/*therapeutic use , Ondansetron/*therapeutic use , Radiotherapy/*adverse effects , Serotonin Antagonists/*therapeutic use , Vomiting/*prevention & control, Antiemetics/administration & dosage ; Antiemetics/adverse effects ; Canada ; Dexamethasone/administration & dosage ; Dexamethasone/adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Nausea/drug therapy ; Nausea/etiology ; Ondansetron/administration & dosage ; Ondansetron/adverse effects ; Quality of Life ; Serotonin Antagonists/administration & dosage ; Serotonin Antagonists/adverse effects ; Treatment Outcome ; Vomiting/etiology